Beese Fulmer Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.8M Buy
7,338
+1,291
+21% +$1.32M 0.51% 50
2026
Q1
$5.56M Buy
6,047
+522
+9% +$529K 0.36% 60
2025
Q4
$5.94M Buy
5,525
+661
+14% +$632K 0.39% 58
2025
Q3
$3.71M Buy
4,864
+1,616
+50% +$1.2M 0.26% 74
2025
Q2
$2.53M Buy
3,248
+1,099
+51% +$854K 0.19% 93
2025
Q1
$1.77M Buy
2,149
+1,544
+255% +$1.28M 0.15% 92
2024
Q4
$467K Sell
605
-4
-0.7% -$3.31K 0.04% 154
2024
Q3
$540K Buy
609
+5
+0.8% +$4.5K 0.05% 148
2024
Q2
$547K Buy
604
+20
+3% +$16K 0.05% 144
2024
Q1
$454K Sell
584
-100
-15% -$71.2K 0.04% 149
2023
Q4
$399K Buy
684
+5
+0.7% +$2.92K 0.04% 163
2023
Q3
$365K Hold
679
0.04% 165
2023
Q2
$318K Buy
679
+1
+0.1% +$419 0.03% 173
2023
Q1
$233K Hold
678
0.03% 197
2022
Q4
$248K Sell
678
-7
-1% -$2.48K 0.03% 192
2022
Q3
$221K Buy
685
+7
+1% +$2.22K 0.03% 193
2022
Q2
$220K Sell
678
-59
-8% -$17.7K 0.03% 206
2022
Q1
$211K Sell
737
-100
-12% -$25.7K 0.02% 219
2021
Q4
$231K Buy
+837
New +$212K 0.02% 217
2020
Q3
Sell
-462
Closed -$76K 393
2020
Q2
$76K Buy
+462
New +$70.9K 0.01% 274

Other funds holding LLY

Beese Fulmer Investment Management's LLY Position: Q2 2026 in Review

Beese Fulmer Investment Management increased its Eli Lilly (LLY) stake by 21% in Q2 2026, buying an estimated $1.32M and bringing the position to 7,338 shares worth $8.8M. The position accounts for 0.51% of the portfolio, ranked #50.

Beese Fulmer Investment Management first reported a position in LLY in Q2 2020 and has held it in 20 quarters since. 2,000 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Beese Fulmer Investment Management held 7,338 shares of Eli Lilly worth $8.8M as of Q2 2026.
  • Beese Fulmer Investment Management bought 1,291 Eli Lilly shares in Q2 2026, an estimated $1.32M.
  • Eli Lilly made up 0.51% of Beese Fulmer Investment Management's portfolio in Q2 2026, its #50 holding.
  • Beese Fulmer Investment Management first reported a position in Eli Lilly in Q2 2020 and has held it in 20 quarters since.
  • 2,000 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Beese Fulmer Investment Management's 13F filing for Q2 2026, filed 29 Jul 2026.